Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.